Current Liabilities
Accrued Liabilities, Current
ResMed Accrued Liabilities, Current increased by 14.0% to $446.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $386.33M to $446.15M. Over 4 years (FY 2021 to FY 2025), Accrued Liabilities, Current shows an upward trend with a 5.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.
Detailed definition
These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...
Peer comparison
Standard across all industries for tracking short-term operational obligations.
Metric ID:
current_liabilities_accrued_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $320.60M | $274.11M | $286.80M | $326.28M | $344.72M | $324.06M | $312.17M | $347.35M | $365.66M | $348.26M | $332.14M | $356.08M | $377.68M | $365.75M | $352.54M | $386.33M | $402.25M | $395.83M | $391.50M | $446.15M |
| QoQ Change | — | -14.5% | +4.6% | +13.8% | +5.7% | -6.0% | -3.7% | +11.3% | +5.3% | -4.8% | -4.6% | +7.2% | +6.1% | -3.2% | -3.6% | +9.6% | +4.1% | -1.6% | -1.1% | +14.0% |
| YoY Change | — | — | — | — | +7.5% | +18.2% | +8.8% | +6.5% | +6.1% | +7.5% | +6.4% | +2.5% | +3.3% | +5.0% | +6.1% | +8.5% | +6.5% | +8.2% | +11.1% | +15.5% |
Range$274.11M – $446.15M
CAGR+7.2%
Avg YoY Growth+8.0%
Median YoY Growth+7.0%
Accrued Liabilities, Current at Other Companies
Frequently Asked Questions
- What is ResMed's accrued liabilities, current?
- ResMed (RMD) reported accrued liabilities, current of $446.15M in Q1 2026.
- How has ResMed's accrued liabilities, current changed year-over-year?
- ResMed's accrued liabilities, current increased by 15.5% year-over-year, from $386.33M to $446.15M.
- What is the long-term trend for ResMed's accrued liabilities, current?
- Over 4 years (2021 to 2025), ResMed's accrued liabilities, current has grown at a 5.8% compound annual growth rate (CAGR), from $320.60M to $402.25M.
- What does accrued liabilities, current mean?
- Short-term expenses that have been incurred but not yet paid.